drugset / Trial / NCT03878693
4-methylpyrazole and Acetaminophen Metabolism
RandomizedSingle-groupOpen-labelOther
Summary
Oxidative metabolism of APAP will be studied with and without 4-MP.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2018-10-31
- Completion
- 2018-10-31
Outcome
Met primary endpoint
paper Compared with APAP alone, co-treatment with 4-MP decreased the percentage of ingested APAP recovered as oxidative metabolites in 24-hour urine from 4.48 to 0.51% PMID 31768936 ↗
paper from 4.48 to 0.51% (95% CI = 2.31-5.63%, p = 0.003). PMID 31768936 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 80 mg/kg | Oral |
| Subject | Fomepizole | Unknown | — | Intravenous |
Indications
No indication recorded.